# Commission Regulation (EC) No 869/2005 of 8 June 2005 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards ivermectin and carprofen (Text with EEA relevance), Division 2.3.1: Avermectins

Extent: E+W+S+N.I.

Not for use in animals from which milk is produced for human consumption.’
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Ivermectin
22,23-Dihydro-avermectin B1a
All mammalian food-producing species
100 μg/kg
Fat
100 μg/kg
Liver
30 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2005/869/annex/division/A/division/2/division/2.3/division/2.3.1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2005-869/annex/division-A/division-2/division-2.3/division-2.3.1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.